OPDIVO® (nivolumab)
OPDIVO® (nivolumab) is a prescription medication that treats certain types of cancer. Read the indications, side effects, and more. Please see Indication and Important Safety Information.
Subcutaneous Injection | OPDIVO® (nivolumab) + Qvantig™ …
Learn more about OPDIVO® (nivolumab) + Qvantig™ (hyaluronidase-nvhy) as a subcutaneous injection treatment option for your fight against cancer. Please see Indication and Important Safety Information.
How This Treatment Works | OPDIVO® (nivolumab)
Learn how OPDIVO® (nivolumab) alone and OPDIVO® + YERVOY® (ipilimumab) in combination work with your immune system to fight cancer. Ask your doctor if these immunotherapies may work for you. Access treatment information for your cancer type.
Advanced PD-L1 Positive NSCLC | Clinical Trial Results |OPDIVO ...
See how OPDIVO® (nivolumab) + YERVOY® (ipilimumab) performed in a clinical trial as first-line treatment for adults with advanced non-small cell lung cancer that tested positive for PD-L1 . Please see Indication and Important Safety Information.
Financial Information: Cost, Access & Affordability - OPDIVO
This is a summary of important information that you need to know about OPDIVO and OPDIVO + YERVOY. Your healthcare team can work with you to help answer any questions you may have about these medications.
What is OPDIVO? OPDIVO is a prescription medicine used to treat: Adults and children 12 years of age and older who have a type of skin cancer called melanoma, and: Whose melanoma has spread or cannot be removed by surgery (advanced melanoma). OPDIVO can be used alone or in combination with YERVOY (OPDIVO + YERVOY).